Translational Development Acquisition Corp.’s (NASDAQ:TDACU) Quiet Period To Expire on February 3rd

Translational Development Acquisition’s (NASDAQ:TDACUGet Free Report) quiet period will expire on Monday, February 3rd. Translational Development Acquisition had issued 15,000,000 shares in its initial public offering on December 23rd. The total size of the offering was $150,000,000 based on an initial share price of $10.00. During the company’s quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Translational Development Acquisition Trading Down 0.1 %

Shares of TDACU opened at $10.04 on Wednesday. Translational Development Acquisition has a 52-week low of $10.00 and a 52-week high of $10.05.

Hedge Funds Weigh In On Translational Development Acquisition

A hedge fund recently bought a new stake in Translational Development Acquisition stock. Tuttle Capital Management LLC bought a new position in shares of Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 25,000 shares of the company’s stock, valued at approximately $461,000. Translational Development Acquisition comprises approximately 2.7% of Tuttle Capital Management LLC’s investment portfolio, making the stock its 9th biggest position.

Translational Development Acquisition Company Profile

(Get Free Report)

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.

See Also

Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.